Alterations in the polarization of liver M1/M2 macrophages upon long-term administration of triptorelin in rats
Open Access
- 28 November 2024
- journal article
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 20 (7) , 511-516
Abstract
Background. Liver macrophages play a pivotal role in maintaining the homeostasis of the liver and the entire body, they may be classified into three categories based on their origin. M1 macrophages, designated as classically activated macrophages, differentiate from macrophages stimulated by interferon-gamma or ligands of Toll-like receptors. M2 cells are derived from macrophages that have been stimulated by IL-4/13. Prostate cancer is the second most prevalent malignancy in men globally. Androgen deprivation therapy using gonadotropin-releasing hormone agonist remains the backbone of advanced prostate cancer treatment. The purpose of our study was to ascertain the impact of testosterone suppression on immunocompetent hepatic cells in male rats. The study employed a series of experimental periods, with the introduction of triptorelin and quercetin at varying stages. Materials and methods. The study was conducted on 35 sexually mature male rats. They were randomly allocated to two groups: the controls (n = 10) and the experimental one (n = 25). The animals in the experimental group were administered a solution of triptorelin at a dose of 0.3 mg of active ingredient per 1 kg of body weight, with the aim of modulating the central deprivation of luteinizing hormone synthesis. We used primary antibodies against CD163 and CD68. Results. In the livers of animals on day 30 of the experiment, the number of CD68+ cells were calculated to be 12.2400 ± 1.5792 per FOV at p < 0.01, which is 2.2 times higher than in the control group. The expression of CD163+ with a value of 25.04 ± 1.79 (p < 0.01) is 5.56 times higher compared to the controls. On day 90, the number of cells exhibiting CD68+ and CD163+ expression was 29.34 ± 1.86 and 25.66 ± 4.22, respectively, at p < 0.01, representing a 5.46-fold increase compared to the FOV in the control group preparations. The 180th day of observation was defined by a reduction in the expression of CD68+ as compared to the earlier examination period. Conversely, the expression of CD163+ in cells increased, representing a 40% rise compared to the previous examination period. On day 270 of the experiment, a gradual increase in the expression of cells with CD68+ (9.86 ± 1.47; p < 0.05) was demonstrated. Conclusions. The long-term administration of triptorelin causes changes in quantitative and qualitative modifications of the macrophage population. Maximum of M1 phenotype are detected at 3 and 12 months of observation. The number of M2 phenotype increases by 6 months of monitoring, with a gradual decrease by 12 months.Keywords
This publication has 29 references indexed in Scilit:
- The mechanism of HMGB1 secretion and releaseExperimental & Molecular Medicine, 2022
- Hepatic macrophages: Key players in the development and progression of liver fibrosisLiver International, 2021
- M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axisCell Death & Disease, 2021
- Liver macrophages in tissue homeostasis and diseaseNature Reviews Immunology, 2017
- Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)Journal of Hepatology, 2016
- Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancerProstate Cancer and Prostatic Diseases, 2011
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptorHepatology, 2008
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1998